RMD - ResMed Inc.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
San Diego,
United States
Type: Equity
RMD price evolution
RMD
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $210.25 | $209.1 | $227.89 | |
| Short term investments | ||||
| Net receivables | $729.74 | $692.39 | $704.91 | |
| Inventory | $933.21 | $958.23 | $998.01 | |
| Total current assets | $2378.08 | $2304.59 | $2367.83 | |
| Long term investments | ||||
| Property, plant & equipment | $705.21 | $657.4 | $665.81 | |
| Goodwill & intangible assets | $3390.03 | $3375.42 | $3322.64 | |
| Total noncurrent assets | $4527.01 | $4436.2 | $4383.88 | |
| Total investments | ||||
| Total assets | $6905.09 | $6740.79 | $6751.71 | |
| Current liabilities | ||||
| Accounts payable | $202.4 | $177.05 | $150.76 | |
| Deferred revenue | $276.31 | $268.21 | $257.26 | |
| Short long term debt | $33.95 | $31.7 | $31.82 | |
| Total current liabilities | $764.07 | $770.8 | $758.53 | |
| Long term debt | $1357.42 | $1463.96 | $1548.09 | |
| Total noncurrent liabilities | $1659.16 | $1719.61 | $1863.27 | |
| Total debt | $1391.37 | $1495.66 | $1579.91 | |
| Total liabilities | $2423.23 | $2490.41 | $2621.8 | |
| Shareholders' equity | ||||
| Retained earnings | $4539.96 | $4401.84 | $4253.02 | |
| Other shareholder equity | -$208.35 | -$320.15 | -$272.53 | |
| Total shareholder equity | $4481.85 | $4250.38 | $4129.9 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $227.89 | $273.71 | $295.28 | $463.16 |
| Short term investments | ||||
| Net receivables | $704.91 | $575.95 | $614.29 | $474.64 |
| Inventory | $998.01 | $743.91 | $457.03 | $416.92 |
| Total current assets | $2367.83 | $1931.48 | $1574.76 | $1523.46 |
| Long term investments | $44.14 | |||
| Property, plant & equipment | $665.81 | $630.5 | $592.07 | $535.68 |
| Goodwill & intangible assets | $3322.64 | $2282.39 | $2320.48 | $2338.49 |
| Total noncurrent assets | $4383.88 | $3164.38 | $3153.37 | $3063.92 |
| Total investments | ||||
| Total assets | $6751.71 | $5095.85 | $4728.13 | $4587.38 |
| Current liabilities | ||||
| Accounts payable | $150.76 | $159.25 | $138.01 | $135.79 |
| Deferred revenue | $257.26 | $204.12 | $201.11 | $185.92 |
| Short long term debt | $31.82 | $31.77 | $35.59 | $33.25 |
| Total current liabilities | $758.53 | $689.3 | $911.77 | $602.76 |
| Long term debt | $1548.09 | $885.78 | $758.13 | $1266.01 |
| Total noncurrent liabilities | $1863.27 | $1045.8 | $930.68 | $1487.59 |
| Total debt | $1579.91 | $917.55 | $793.72 | $1299.26 |
| Total liabilities | $2621.8 | $1735.1 | $1842.45 | $2090.35 |
| Shareholders' equity | ||||
| Retained earnings | $4253.02 | $3613.74 | $3079.64 | $2832.99 |
| Other shareholder equity | -$272.53 | -$312.75 | -$193.49 | -$283.98 |
| Total shareholder equity | $4129.9 | $3360.75 | $2885.68 | $2497.03 |
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1162.8 | $1102.32 | $1122.06 | |
| Cost of revenue | $515.87 | $502.26 | $504.67 | |
| Gross Profit | $646.93 | $600.06 | $617.39 | |
| Operating activities | ||||
| Research & development | $73.88 | $75.71 | $78.14 | |
| Selling, general & administrative | $222.16 | $222.87 | $240.69 | |
| Total operating expenses | $371.84 | $311.06 | $342.12 | |
| Operating income | $275.09 | $289 | $275.27 | |
| Income from continuing operations | ||||
| EBIT | $273.26 | $287.15 | $291.75 | |
| Income tax expense | $50.65 | $52.77 | $47.14 | |
| Interest expense | $13.8 | $14.96 | $14.94 | |
| Net income | ||||
| Net income | $208.8 | $219.42 | $229.66 | |
| Income (for common shares) | $208.8 | $219.42 | $229.66 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4222.99 | $3578.13 | $3196.82 | $2957.01 |
| Cost of revenue | $1867.33 | $1553.82 | $1357.72 | $1239.23 |
| Gross Profit | $2355.66 | $2024.31 | $1839.1 | $1717.79 |
| Operating activities | ||||
| Research & development | $287.64 | $253.57 | $225.28 | $201.95 |
| Selling, general & administrative | $874 | $739.37 | $670.39 | $676.69 |
| Total operating expenses | $1223.79 | $1024.03 | $935.42 | $908.13 |
| Operating income | $1131.87 | $1000.29 | $903.68 | $809.66 |
| Income from continuing operations | ||||
| EBIT | $1149.04 | $982.79 | $907.65 | $773.47 |
| Income tax expense | $204.11 | $181.05 | $409.16 | $111.41 |
| Interest expense | $47.38 | $22.31 | $23.99 | $40.38 |
| Net income | ||||
| Net income | $897.56 | $779.44 | $474.5 | $621.67 |
| Income (for common shares) | $897.56 | $779.44 | $474.5 | $621.67 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $208.8 | $219.42 | $229.66 | $232.5 |
| Operating activities | ||||
| Depreciation | $53.37 | $53.44 | $55.2 | $52.79 |
| Business acquisitions & disposals | -$7.5 | -$103.18 | -$1.52 | |
| Stock-based compensation | $19.84 | $18.51 | $19.93 | $17.83 |
| Total cash flows from operations | $272.83 | $286.28 | $237.44 | $282.56 |
| Investing activities | ||||
| Capital expenditures | -$23.35 | -$30.04 | -$34.45 | -$28.82 |
| Investments | -$9.08 | -$4.93 | -$6.26 | $3.12 |
| Total cash flows from investing | -$41.14 | -$148.98 | -$46.52 | -$28.1 |
| Financing activities | ||||
| Dividends paid | -$70.68 | -$70.6 | -$64.7 | -$64.64 |
| Sale and purchase of stock | -$30.48 | $0.98 | $23.49 | $0.98 |
| Net borrowings | -$130 | -$80 | -$145 | -$215 |
| Total cash flows from financing | -$238.96 | -$151.13 | -$188.59 | -$279.56 |
| Effect of exchange rate | $8.42 | -$4.96 | -$2.33 | -$0.21 |
| Change in cash and equivalents | $1.15 | -$18.79 | -$0 | -$25.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $897.56 | $779.44 | $474.5 | $621.67 |
| Operating activities | ||||
| Depreciation | $197.56 | $193.84 | $191.52 | $181.37 |
| Business acquisitions & disposals | -$1012.75 | -$42.78 | -$39.07 | -$27.91 |
| Stock-based compensation | $71.14 | $65.26 | $63.93 | $57.56 |
| Total cash flows from operations | $693.3 | $351.15 | $736.72 | $802.25 |
| Investing activities | ||||
| Capital expenditures | -$119.67 | -$134.84 | -$102.71 | -$95.33 |
| Investments | -$13.1 | -$31.1 | -$2.57 | -$46.01 |
| Total cash flows from investing | -$1159.85 | -$229.92 | -$158.46 | -$179.86 |
| Financing activities | ||||
| Dividends paid | -$258.28 | -$245.34 | -$226.71 | -$225.09 |
| Sale and purchase of stock | $49.14 | $47.38 | $37.79 | $48.18 |
| Net borrowings | $665 | $122 | -$522 | -$94.01 |
| Total cash flows from financing | $422.87 | -$128.36 | -$764.63 | -$317.29 |
| Effect of exchange rate | -$2.15 | -$14.43 | $18.5 | $10.92 |
| Change in cash and equivalents | -$45.82 | -$21.57 | -$167.88 | $316.03 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.63 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |